Phosphorylation stoichiometries of human eukaryotic initiation factors. by Andaya, Armann et al.
Lawrence Berkeley National Laboratory
Recent Work
Title
Phosphorylation stoichiometries of human eukaryotic initiation factors.
Permalink
https://escholarship.org/uc/item/6d06r221
Journal
International journal of molecular sciences, 15(7)
ISSN
1422-0067
Authors
Andaya, Armann
Villa, Nancy
Jia, Weitao
et al.
Publication Date
2014-06-27
DOI
10.3390/ijms150711523
 
Peer reviewed
eScholarship.org Powered by the California Digital Library
University of California
Int. J. Mol. Sci. 2014, 15, 11523-11538; doi:10.3390/ijms150711523 
 
International Journal of 
Molecular Sciences 
ISSN 1422-0067 
www.mdpi.com/journal/ijms 
Article 
Phosphorylation Stoichiometries of Human Eukaryotic 
Initiation Factors 
Armann Andaya, Nancy Villa, Weitao Jia, Christopher S. Fraser and Julie A. Leary * 
Department of Molecular and Cellular Biology, University of California at Davis, Davis, CA 95616, 
USA; E-Mails: aaandaya@ucdavis.edu (A.A.); nvilla@ucdavis.edu (N.V.); wtjia@ucdavis.edu (W.J.); 
csfraser@ucdavis.edu (C.S.F.) 
* Author to whom correspondence should be addressed; E-Mail: jaleary@ucdavis.edu;  
Tel.: +1-530-752-4685. 
Received: 20 March 2014; in revised form: 11 April 2014 / Accepted: 29 April 2014 /  
Published: 27 June 2014 
 
Abstract: Eukaryotic translation initiation factors are the principal molecular effectors 
regulating the process converting nucleic acid to functional protein. Commonly referred to 
as eIFs (eukaryotic initiation factors), this suite of proteins is comprised of at least  
25 individual subunits that function in a coordinated, regulated, manner during mRNA 
translation. Multiple facets of eIF regulation have yet to be elucidated; however, many of 
the necessary protein factors are phosphorylated. Herein, we have isolated, identified and 
quantified phosphosites from eIF2, eIF3, and eIF4G generated from log phase grown HeLa 
cell lysates. Our investigation is the first study to globally quantify eIF phosphosites and 
illustrates differences in abundance of phosphorylation between the residues of each  
factor. Thus, identification of those phosphosites that exhibit either high or low levels of 
phosphorylation under log phase growing conditions may aid researchers to concentrate 
their investigative efforts to specific phosphosites that potentially harbor important 
regulatory mechanisms germane to mRNA translation. 
Keywords: mass spectrometry; eukaryotic initiation factor; translation; phosphorylation 
quantification  
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1. Introduction 
The process of converting nucleic acid to functional protein, a process involving the precise  
spatial and temporal arrangement of proteins, protein complexes, and nucleic acids, is known as  
translation [1–3]. Initiation, elongation, termination, and recycling constitute the four chronological 
phases of mRNA translation with initiation bearing the greatest regulation. The principal molecules 
that regulate initiation for eukaryotes are the eukaryotic initiation factors (eIFs), a family which is 
comprised of 12 members encompassing at least 25 individual proteins [1]. One of the most common 
means of regulating proteins involves phosphorylation, a well-established post-translational modification. 
Herein, we report our global investigation of phosphorylation quantification for three essential 
eukaryotic initiation factors, eIF2, eIF3, and eIF4G. 
At the onset of eukaryotic translation initiation, the 40S ribosome binds several factors including 
eIF2 and eIF3 to form the 43S preinitiation complex (PIC). eIF2 (a heterotrimer consisting of the 
proteins eIF2α, eIF2β, and eIF2γ) binds as a ternary complex (TC) comprised of eIF2, the initiator 
methionyl tRNA (Met-tRNAi), and GTP (guanosine triphosphate). The PIC can then bind to nascent 
messenger RNA (mRNA) through the direct interaction of eIF3 and eIF4G, a member of the eIF4F 
cap-binding complex. The largest of the eIFs, eIF3 is comprised of thirteen distinct subunits with a 
holoprotein mass of approximately 800 kDa. Numerous studies implicate the holoprotein eIF3 and its 
many subunits as an essential factor during translation initiation: It is the central assembly on which 
other factors, proteins, and nucleic acids bind [4–10]. The factor eIF4F is also an essential protein to 
translation initiation. It is comprised of three other eIFs: eIF4A, eIF4E, and the largest of the three, 
eIF4G with a mass of 176 kDa. eIF4G functions as a scaffolding protein onto which other factors, such 
as eIF3, eIF4A, and eIF4E functionally interact [11–13]. 
Although each subunit has a defined function during translation initiation, the regulatory 
mechanisms governing initiation have yet to be entirely solved. Protein phosphorylation, albeit a  
well-established post-translational modification, is still not completely understood, particularly in eIFs, 
as regards target specificity. However, the resulting effects once a protein is phosphorylated can be 
dramatic as that of ser-51 phosphorylation on eIF2α, which has been extensively studied and serves as 
a prime example of the effect phosphorylation has on the initiation process. 
During initiation, eIF2 TC hydrolyzes GTP then releases Met-tRNAi following start codon 
recognition. eIF2B, a GTP exchange factor (GEF) for eIF2, exchanges GDP (guanosine diphosphate) 
for GTP, which then promotes binding of a new Met-tRNAi for further rounds of translation. 
Phosphorylation of eIF2α at ser-51 reduces the dissociation rate of eIF2 from eIF2B, effectively 
sequestering eIF2B and preventing eIF2 TC regeneration and thus globally repressing the rate of 
mRNA translation [14–18]. The largest protein of the three subunits, eIF2γ, functions as a scaffolding 
protein on which the remaining subunits bind. We recently identified eight novel sites of phosphorylation 
on eIF2γ and demonstrated the potential in vitro effects of eIF2γ phosphorylation via protein kinase C 
(PKC) [19]. 
In addition to the identification of novel phosphosites, determining those levels of phosphorylation 
on specific residues allows researchers to define potentially important phosphosites, thereby 
distinguishing those sites from potentially less biologically meaningful ones [20–26]. As with eIF2α, 
phosphorylation at ser-51 becomes more pronounced under conditions of cellular stress which 
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demonstrates how the fluidity of the phosphorylation stoichiometry reveals intrinsic mechanisms 
implicated in regulating phosphorylation in response to cellular cues [14–18]. Establishment of 
phosphosite stoichiometry under specific biological conditions may help to focus ensuing investigations 
for deciphering biologically important phosphosites. 
While identification of novel phosphosites is the essential first step in the eventual evaluation of 
their biological impact, follow-up studies, even on a few novel sites of phosphorylation, often presents 
a task too burdensome for subsequent in-depth investigations. Researchers identify phosphosites for 
further study through evaluation of their structural location. Phosphosites residing in structurally 
salient locations such as established binding sites, binding pockets, or areas of significant secondary, 
tertiary, and/or quaternary structure, are considered desirable candidates for further evaluation. 
However, without such informative data, further investigations into newly discovered phosphosites are 
often avoided. 
In order to assess the amount of phosphorylation occurring at specific residues, we recently 
published a mass spectrometry method proficient at measuring phosphosite stoichiometry [27]. Our 
method relies on the measurement of dephosphorylation of phosphopeptides accomplished chemically 
via cerium oxide [28]. We have further optimized cerium oxide’s capacity for dephosphorylating 
peptides and have subsequently developed a method to measure the amount of dephosphorylation via 
tandem mass tags (TMT) [25]. Use of the isobaric TMT reporter ions allows for assessment of 
phosphorylation stoichiometry. We have verified the use of this quantification protocol and have 
shown its efficacy in measuring the stoichiometry of previously established phosphosites. One of the 
subunits of eIF3, eIF3h, has one previously identified phosphorylation site, ser-183 [29], and we have 
now determined its level of phosphorylation to be 70% in log phase grown HeLa cells (data provided 
and discussed in the results section). This observation coincides with the critical in vivo effects of 
eIF3h’s ser-183 phosphorylation during malignant transformation of NIH 3T3 cells [27,30]. 
This report is the first to highlight the phosphorylation levels of three heavily phosphorylated 
eukaryotic initiation factors. Additionally, our quantification analysis is specific to the analysis of cells 
grown at optimal conditions and thus underscores the importance of variability possible with these 
phosphosites under different environmental circumstances. Knowledge gained from this study provides 
a platform for future investigations not only for phosphorylated proteins, but also for the inherent 
variability of specific phosphosites within the protein itself. Hence, the purpose of this study is to add 
to the growing pool of knowledge of these factors and more importantly, to initiate an investigation 
primarily aimed at quantified phosphorylated residues and their implication on translation initiation. 
Future studies into the regulation of these factors may be based on the findings within this study. 
2. Results and Discussion 
2.1. Quantification of Phosphorylation for Eukaryotic Initiation Factor 2 (eIF2) 
We isolated eIF2 from HeLa cell lysate in order to quantify its level of phosphorylation. The factor 
was purified from HeLa cells under optimal growth conditions (log phase growth). As eIF2 is a 
heterotrimer with a molecular mass of 126 kDa, we analyzed the two factors that have been previously 
reported as phosphorylated within HeLa cells, eIF2β and eIF2γ. While eIF2α has been heavily studied 
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at its principally phosphorylated residue of ser-51, quantification of that residue does not lead to new 
information or developments, which is the principal aim of this study. Thus, we focused our efforts at 
quantifying the numerous sites on the remaining two subunits of eIF2 in order to gain further insight 
into their function and regulation. 
Recently, we published the identification of eight sites of phosphorylation, seven of which were 
novel and reside on the largest subunit, eIF2γ, the core subunit of the heterotrimer [19]. All identified 
phosphosites were quantified. On eIF2γ, numerous functional domains exist dedicated to specific tasks 
during eukaryotic translation. Threonine 66, a phosphorylated residue, is located within the switch-1 
region of the protein, and in this study, we observed its level of phosphorylation at 71% (Figure 1). 
Two sites adjacent to one another, ser-55 and thr-56, reside directly in the nucleotide binding pocket of 
eIF2γ and our quantitative phosphoanalysis revealed the levels of phosphorylation to be 85% for both 
ser-55 and thr-56 combined (Supplementary Information). Proximal to the C-terminal end of the 
protein, ser-412 and thr-413 exhibit phosphorylation at 7% while ser-418 and thr-435 have 
phosphorylation at 70% and 60%, respectively (Supplementary Information). Lastly, thr-109’s 
phosphorylation level was observed at 30% and this residue sits adjacent to the zinc binding domain 
(Supplementary Information). 
Figure 1. Quantification of phosphorylation on Thr-66 on eIF2γ. (A) Precursor ion mass 
scan of the [M + 2H]2+ ion is shown; (B) MS/MS spectra of m/z ion 582.9 illustrating 
indicative b- and y-ions for peptide spanning residues 60–68 of eIF2γ; and (C) Zoomed in 
view of the m/z region containing the TMT (tandem mass tags) reporter ions. Calculation 
of the reporter ion ratio reveals a phosphorylation level of 70.5% for Thr-66. 
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In contrast to eIF2γ, eIF2β has a lower abundance of phosphorylated residues within HeLa cells. 
Nevertheless, we quantified these sites and observed levels of 18% for thr-31 but near or less than 5% 
for the other reported eIF2β phosphosites (Table 1). 
Table 1. Three of the factors, eIF2, eIF3, and eIF4G were analyzed as to their 
quantification of phosphorylation levels within log phase grown HeLa cells. Percentages of 
the phosphosites are shown. 
Protein Subunit Residue Phosphorylated % Phosphorylation 
eIF2 
β 
Thr-31 18 
Ser-67 <5 
Ser-105 <5 
Thr-111 <5 
Ser-158 8 
γ 
Ser-55 85 
Thr-56 85 
Thr-66 71 
Thr-109 30 
Ser-412 7 
Thr-413 7 
Ser-418 70 
Thr-435 66 
eIF3 
a 
Ser-881 84 
Ser-1198 92 
Ser-1336 18 
Ser-1364 36 
b 
Ser-83 85 
Ser-85 85 
Ser-119 70 
Ser-125 70 
c Thr-524 95 
g Thr-41 31 Ser-42 31 
h Ser-183 89 
j Thr-109 88 
eIF4G - 
Thr-647 65 
Ser-1028 5 
Ser-1077 15 
Ser-1092 40 
Ser-1144 45 
Ser-1147 45 
Ser-1185 70 
Ser-1187 70 
Ser-1209 50 
Thr-1211 50 
Ser-1231 75 
Thr-1425 62 
Ser-1430 62 
Ser-1596 <5 
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2.2. Quantification of Phosphorylation for Eukaryotic Initiation Factor 3 (eIF3) 
Although the exact structure and placement of each subunit within the tridodecamer of eIF3 has yet 
to be fully solved, the number of phosphorylations derived from log phase HeLa cells is 29 [29]. We 
thus sought to quantify the levels of each of these 29 sites of phosphorylation. Given that each subunit 
is a distinct protein, the varying levels of phosphorylation from subunit to subunit or within each 
subunit should not be surprising. 
The core subunits of eIF3 are widely believed to be eIF3a, eIF3b, and eIF3c, the three largest of  
the thirteen subunits. These three subunits house 21 of the 29 sites of phosphorylation for eIF3, 15 of 
which were accurately quantified. The largest subunit, eIF3a, has a varied landscape of phosphorylation 
ranging from 18% for ser-1336 to a high of 92% for ser-1198 (Figure 2). Intriguing are the two 
phosphorylated residues at the C-terminal end (or C-Terminus) of the protein, ser-1336 and ser-1364. 
While ser-1336 has a phosphorylation of 18%, ser-1364 has a level of 36% (Supplementary 
Information). The exact crystal structure of human eIF3a has yet to be solved, but from this study, we 
see that the C-terminal phosphorylated residues are lower in phosphorylation levels than that for  
ser-1198 at 92% and for that of ser-881 at 84%. This rather high level of phosphorylation for these 
residues may implicate functional significance for eIF3 quaternary structure given that the C-terminal 
phosphorylated residues possess a lower level of phosphorylation. 
The second largest eIF3 subunit, eIF3b, has 7 sites of phosphorylation. Unfortunately, we did not 
attain full sequence coverage for all proteins analyzed which lead to a lack of quantification for some 
previously identified phosphosites. This was due in part to either the absence of a lysine or arginine 
within the vicinity of the phosphosite in question or an inadequacy of sufficient identifiable b- and  
y-ions. However, as with eIF3a’s ser-1198 and ser-881, the levels of phosphorylation for eIF3b were 
relatively large ranging from 70% for both ser-119 and ser-125, and 85% for both ser-83 and ser-85 
(Supplementary Information). Again, implications in eIF3 quaternary structure for these high levels of 
phosphorylation will be investigated further. 
The third largest purported eIF3 core subunit is eIF3c. Again, due to the same limitations as 
previously mentioned, the N-terminal phosphorylated residues of ser-9, ser-11, ser-13, ser-15, ser-16, 
ser-18, and ser-39 could not be quantified. But as with subunits eIF3a and eIF3b, higher levels of 
phosphorylation were observed for thr-524 at 95% (Supplementary Information). 
Regarding the subunit eIF3h, we have already published a report detailing its relatively high level 
of phosphorylation from log phase HeLa cells at 70% and within the current study, 89% [27]. This 
high level of phosphorylation is in direct correlation with biological data showing that mutation of this 
residue to alanine produced a decrease in growth rate of NIH-3T3 cells [30]. Residues not quantified 
for eIF3 due to previously mentioned experimental limitations were eIF3f (ser-258) and the N-terminal 
residues of eIF3j (ser-11, ser-13, and ser-20). A level of 31% phosphorylation was observed for 
eIF3g’s two phosphorylated residues, thr-41 and ser-42, and a high level of phosphorylation 
comparable to that of eIF3h was observed for thr-109 on eIF3j (Table 1 and Supplementary Information). 
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Figure 2. Quantification of phosphorylation on eIF3. (A) MS/MS spectra of m/z ion 406.6, 
z = 3. Peptide spans residues 1329–1337 for eIF3a; (B) Zoomed in view of the m/z region 
containing the TMT reporter ions. Calculation of the reporter ion ratio reveals a 
phosphorylation level of 18% for Ser-1336; (C) MS/MS spectra of m/z ion 405.5, z = 3. 
Peptide spans residues 1194–1201 for eIF3a; and (D) Zoomed in view of the m/z region 
containing the TMT reporter ions. Calculation of the reporter ion ratio reveals a 
phosphorylation level of 92% for Ser-1198.  
 
2.3. Quantification of Phosphorylation for Eukaryotic Initiation Factor 4G (eIF4G) 
A large scaffolding protein, eIF4G commonly occurs with varying isoforms that are dependent on 
the location of the start codon. Nonetheless, the principal isoform of the protein is comprised of  
1599 amino acids with a molecular mass of 176 kDa. Prior to translation initiation, eIF4G serves as  
a docking site to which other proteins bind prior to forming larger complexes necessary for the 
translation process. Known proteins that bind to eIF4G are poly A binding protein (PABP), the kinase 
Mnk1, and initiation factors eIF4E, eIF4A, and eIF3. The phosphorylation of eIF4G from HeLa cells 
has been well documented with evidence of up to 20 sites of phosphorylation corresponding to eIF4G 
derived from HeLa cells have been identified. However, as with all other eIFs, the quantification of 
this phosphorylation has yet to be reported. 
Currently, considerable investigation has focused on the portion of eIF4G that has been mapped  
to bind to eIF3 [31]. This portion, corresponding to residues 1015 to 1105, contains three sites of 
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phosphorylation identified from HeLa cells, ser-1028, ser-1077, and ser-1092. Quantification of each 
site of phosphorylation reveals 5%, 15%, and 40% for ser-1028, ser-1077, and ser-1092, respectively 
(Figure 3). The only other site of phosphorylation that maps to a known binding region on eIF4G is 
located at the C-terminus of the protein and is ser-1596 that corresponds to the Mnk1 binding region. 
Quantification of its phosphorylation reveals less than 5% levels of phosphorylation. 
As for the remaining known sites of phosphorylation for eIF4G from HeLa cells, insufficiently 
scored peptides prevented our quantitative analysis of phosphosites residing in the N-terminal portion 
of the protein. However, high levels of phosphorylation were observed for thr-647 at 65%. Regions 
near but distinct from the eIF3 binding site had phosphorylation levels at or near 50%. The peptide 
mapped to ser-1144 and ser-1147 had a combined level of 45% and the peptide mapped to ser-1209 
and ser-1211 was at 50%. The peptide mapping to ser-1185 and ser-1187 had a level of 70% and the 
peptide mapping to ser-1231 had a level of 75%. Peptides mapping in close proximity to the Mnk1 
binding region, thr-1425 and ser-1430 were quantified at phosphorylation levels of 62%. 
Figure 3. Quantification of phosphorylation on eIF4G. (A) MS/MS spectra of m/z ion 
992.6, z = 2. Peptide spans residues 1072–1085; (B) Zoomed in view of the m/z region 
containing the TMT reporter ions. Calculation of the reporter ion ratio reveals a 
phosphorylation level of 15% for Ser-1077; (C) MS/MS spectra of m/z ion 520.8, z = 2. 
Peptide spans residues 1091–1095; and (D) Zoomed in view of the m/z region containing 
the TMT reporter ions. Calculation of the reporter ion ratio reveals a phosphorylation level 
of 40% for Ser-1092. 
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The entire process of translation initiation requires a concerted and choreographed effort from 
numerous proteins to effectively translate the nascent mRNA into functional protein. Although the 
process of translation may be separated into the four distinct phases of initiation, elongation, 
termination, and recycling, much of the regulation is centralized to the initiation phase. Translation 
initiation is the process by which the 40S ribosome, bound to Met-tRNAi and several initiation factors, 
binds to the 5' end of mRNA then scans in the 5' to 3' direction until the initiation codon is recognized. 
Recruitment of Met-tRNAi requires formation of a ternary complex also containing eIF2 and GTP, 
while mRNA recruitment to the ribosome complex requires binding of eIF4G and eIF3. 
As the formation of the ternary complex is critical to translation, a better understanding of the major 
protein component, eIF2, would help define this process. A closer look into the function of eIF2 
reveals that the heterotrimer consists of three subunits, eIF2α and eIF2β bound to eIF2γ but not each 
other. Classically, eIF2α’s phosphorylation on ser-51 converts the eIF2 heterotrimer into an inhibitor 
of eIF2B, the heteropentamer responsible for exchanging GDP for GTP on eIF2. Since the 
phosphorylation of this one residue on eIF2α has a profound impact on the overall process of 
translation, we hypothesized that the other subunits of eIF2 may also contribute in some part to the 
overall process of translation. 
Our phosphoanalysis of eIF2 centered on known phosphosites for both eIF2β and eIF2γ derived from 
HeLa cells. In our previous report for eIF2γ, one of the novel phosphosites identified was thr-66 [19]. 
Further investigations of this site were conducted based on previous structural studies placing it within 
eIF2γ’s switch 1 region [32,33]. As eIF2 forms a ternary complex with met-tRNAi and GTP, the switch 1 
region of the molecule undergoes a conformational change in order to allow for complexation [34,35]. 
Our previous report revealed not only phosphorylation of thr-66, but also established PKC as a kinase 
with the ability to phosphorylate thr-66 in vitro. In the current study, we observed that for cells 
propagated under log-phase growth conditions, thr-66 on eIF2γ is 71%. Given that a majority of thr-66 is 
phosphorylated for a cancer cell line under optimal conditions, future discernment of the physiological 
role of this phosphosite should be of paramount importance. Logically, phosphorylation within this 
region of the molecule may have a significant impact on the protein’s overall structure and consequently 
its influence on the conformational change experienced upon GTP binding to eIF2γ. 
Two other structurally noteworthy phosphorylation sites are ser-55 and thr-56 [36,37]. Both of these 
sites reside directly within the nucleotide binding pocket of eIF2γ. As eIF2γ represents the core protein 
of the eIF2 heterotrimer, it binds directly to eIF2α and eIF2β, yet the α and β subunits do not bind to 
each other [38,39]. Two-thirds of the ternary complex forms upon GTP binding to the heterotrimer, 
specifically, to eIF2γ. In its inactive form, GDP is bound along with a magnesium molecule in eIF2γ’s 
binding pocket. Our quantitative phosphoanalysis revealed that the level of phosphorylation is 
approximately 85% for both ser-55 and thr-56 combined. As with most phosphorylation quantification 
protocols, phosphosites residing on the same tryptic peptide are difficult to quantify individually [40]. 
Nonetheless, a level of 85% phosphorylation within the nucleotide binding pocket raises some 
intriguing possibilities. Phosphorylation in this binding pocket may potentially present itself as a 
regulatory mechanism eliciting steric strain, which could prevent binding of an additional nucleotide. 
Such a high level of phosphorylation within this binding pocket most likely influences the interplay  
of magnesium and GTP binding. The temporal aspects of kinase and/or phosphatase interplay  
with GTP and magnesium binding necessitate future investigations. The possibility of enzyme-aided 
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phosphorylation diminishes with such a small binding pocket thus raising questions of this event 
possibly occurring prior to protein folding. Clearly, future studies are needed to determine the effects 
of such high levels of phosphorylation within an important region of the protein. 
In contrast to those phosphosites near the binding pocket and within the switch 1 region, 
phosphosites associated with the C-terminal portion of the protein, ser-412 and thr-413 have levels at 
7% while ser-418 and thr-435 are at or near 70%. Thus, from the current study, we can see the 
dynamics of the phosphorylation landscape unfold. Residues 412 and 413 reside on the outer face of 
the molecule and despite the fact that they may be more readily available to kinases as compared to 
residues 55, 56, and 66, (which lie on the interior of the molecule), their levels of phosphorylation are 
significantly smaller. Future investigations will determine the significance of these phosphorylation 
stoichiometries, but for now, we can speculate that phosphorylation does not play a major role in the 
binding to other nucleotides and/or proteins. The same appears not to be true for either ser-418 or  
thr-435. Again, future studies will determine these residues’ phosphorylation significance, but 
undoubtedly, different physiological circumstances and pressures exist on the phosphorylated residues 
of the C-terminal of eIF2γ. Such a variation of phosphorylation may imply a structural necessity 
adopted by the C-terminus during the binding processes. It would be interesting to observe 
phosphorylation differences not only under different growth conditions, but also when one of the four 
C-terminal sites is mutated and how this effect translates to the overall phosphorylation landscape 
across the C-terminal region. 
Lastly, thr-109’s phosphorylation level at 30% seems to neither weaken nor strengthen the 
importance of this phosphosite to the overall physiology of eIF2. However, as stated in our previous 
report, this residue does reside near a zinc binding domain. The electrostatics involved with the zinc 
cation and the negative charge inherent in a phosphate moiety could be responsible for an interaction 
that may determine the proper positioning of the zinc ion. Proteins containing zinc binding motifs have 
been well documented in their binding affinity for nucleotides. As eIF2 binds to met-tRNAi and is part 
of the ternary complex that shuttles this polynucleotide to the awaiting mRNA during protein 
translation initiation, the interplay of the phosphate on thr-109 and the zinc ion may have a meaningful 
impact on protein translation. 
Considerable more research is required to decipher the significance of eIF2β phosphosite structural 
regions. Previous targeted investigations into eIF2β have established an interaction of the protein with 
the kinase CK2 and suggest numerous physiological pressures affecting the dynamics of eIF2β 
phosphorylation warranting further investigation [41]. Nonetheless, our report represents the first 
measurements of the levels of quantification of these phosphosites. Aside from ser-51 on eIF2α, the 
phosphosites of eIF2β and eIF2γ are not only dynamic, but may house important functions necessary 
for translation initiation [42]. 
Along with eIF2, eIF3 is a necessary initiation factor as it binds to many of the numerous eIFs 
including eIF4A, eIF1, eIF1A, eIF2, and eIF4G. A critical function of eIF3 is prevention of premature 
association to the 60S ribosome by binding to the 40S ribosome along with other initiation factors. 
Although its function and structure have been previously investigated, to date eIF3 has neither a 
definitive crystal structure nor have any of its phosphorylation sites been thoroughly investigated. 
Recent studies have shown the structure of the tridodecamer as a 5 lobed entity comprised of a core 
with five protrusions [43]. The exact structure of each of the lobes has yet to be fully determined, but 
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mass spectrometry along with reconstitution of a recombinant tridodecamer has indicated the core 
subunits, eIF3a, eIF3b, and eIF3c, as being the three largest [10,44,45]. Interestingly, these same three 
subunits contain 21 of the 29 possible phosphorylation sites for eIF3. All three of the purported core 
subunits have high levels of phosphorylation. As the quaternary structure of eIF3 may rely heavily on 
the integrity of its core proteins, a high level of phosphorylation, especially from log phase grown 
cells, suggests an increasing role of electrostatic interactions that possibly strengthen the integrity of 
the entire complex. Levels of phosphorylation were not as elevated for the other phosphorylated 
subunits except for that of eIF3j. However, eIF3j has been known to disassociate from the other  
12 subunits of eIF3 thus a high level of phosphorylation for thr-109 may be indicative of an increased 
affinity to the holoprotein during translation [7,8]. Future investigations will help determine the nature 
of each of these phosphosites. 
The final protein whose phosphorylation was quantified in this study was eIF4G. A classic example 
of a scaffolding protein, much like the core proteins of eIF3, phosphorylation was present at its highest 
level for residues residing in known areas of protein binding. Three phosphorylated residues lie within 
the eIF3 binding region of eIF4G and all three exhibited high levels of phosphorylation. Other residues 
that also showed high levels of phosphorylation are residues between the eIF3 and eIF4A binding 
regions. Although future investigations will decipher the role of these specific phosphosites, 
phosphosite ser-1187 is known in HEK293 cells to function as a substrate for the kinase PKCα and 
modulates Mnk1 binding [30]. Again, phosphorylated residues implicated in binding appear to have 
the highest levels of phosphorylation. 
3. Experimental Section 
3.1. Purification of eIFs from HeLa Cell Lysate 
All proteins for this study, eIF2, eIF3, and eIF4G were enriched from HeLa cell lysate prior to 
nano-LC-MS/MS according to previously published protocols [19,29]. Briefly, HeLa cell lysate  
(from approximately 30 L cells) was quickly thawed at 37 °C supplemented in a mixture including  
10% glycerin, 1 mM EDTA, 1 mM EGTA, 50 mM NaF, 50 mM beta-glycerol phosphate, 10 mM 
benzamidine, 1 mM DTT, and 1× protease inhibitor mixture (Roche, Basel, Switzerland). After stirring 
for 10 min at 4 °C, the mixture was centrifuged at 20,000× g for 20 min at 4 °C. To the resulting 
supernatant, KCl was added to a final concentration of 450 mM followed by centrifugation in a 
Beckman Ti-45 rotor for 4 h at 4 °C at 45,000 rpm. The middle two-thirds of the supernatant was 
carefully removed and stirred at 4 °C while saturated ammonium sulfate was added to a final 
concentration of 40%. After stirring on ice for 1 h, the suspension was centrifuged at 20,000× g for  
10 min at 4 °C and the pellet (referred to as the A cut) was frozen for future use. To the remaining 
supernatant, ammonium sulfate was added to a final concentration of 70%. After stirring for 1 h, the 
mixture was centrifuged at 20,000× g for 10 min at 4 °C. The pellet (the B cut) was resuspended in  
50 mL of buffer A (20 mM HEPES, pH 7.5, 10% glycerol, 1 mM EDTA, 1 mM EGTA, 50 mM NaF, 
50 mM β-glycerol phosphate, 10 mM benzamidine, 1 mM DTT) containing 50 mM KCl and dialyzed 
in two liters of the same buffer for 2.5 h at 4 °C. Following dialysis, the lysate was passed through a 
0.2 µm syringe filter and loaded onto a MonoQ (10/10) column (GE Healthcare, Sunnyvale, CA, USA). 
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The column was eluted with a linear gradient of 100 to 500 mM KCl in buffer A at 2 mL/min with 3 mL 
fractions collected. The fractions that contained the protein of interest (either eIF2, eIF3, or eIF4G) 
were then pooled, dialyzed against buffer A containing 100 mM KCl for 2.5 h at 4 °C, and loaded onto 
a MonoS (10/10) column (GE Healthcare, Sunnyvale, CA, USA). The same gradient as that of the 
MonoQ column was applied and fractions from the MonoS column were analyzed using SDS-PAGE 
in a similar fashion. Fractions containing the protein of interest were pooled and loaded onto a 
hydroxyapatite column made in-house using commercial hydroxyapatite (Calbiochem, San Diego, CA, 
USA). Elution was performed using a linear gradient from 0% to 100% 0.5 M potassium phosphate 
buffer at pH 7.5. Fractions were again analyzed via SDS-PAGE in a similar manner to those eluting 
from either the MonoQ or MonoS columns. Fractions containing the now purified protein were pooled 
and concentrated using Amicon Ultra filtration devices with a MWCO of 10,000 Da to yield a final 
concentration between 1 and 2 mg/mL. 
3.2. Tryptic Digestion of eIFs with Subsequent Tandem Mass Tag (TMT) Labeling 
Each eIF protein was digested with trypsin following the same protocol. Approximately 1 µmol of 
either eIF2, eIF3, or eIF4G was first reduced at 56 °C for 45 min in 5.5 mM DTT final concentration 
followed by alkylation for one hour in the dark with iodoacetamide (IAA) added to a final 
concentration of 10 mM. Trypsin was added at a final enzyme:substrate mass ratio of 1:50 and 
digestion carried out overnight at 37 °C. The reaction was quenched by flash freezing in liquid 
nitrogen and the digest was lyophilized. Prior to TMT labeling, each lyophilized sample was dissolved 
into 100 µL of 2% acetonitrile supplemented with 0.1% trifluoroacetic acid.  
All eIF peptides were prepared for TMT labeling following our published protocol [27]. Briefly, 
each eIF peptide mixture was divided equally; one population was treated with cerium oxide 
nanopowder (Sigma-Aldrich, St. Louis, MO, USA) to dephosphorylate the phosphopeptides, the other 
half was left untreated. Subsequent to dephosphorylation, the dephosphorylated samples were labeled 
with TMT-126. The remaining untreated half was labeled with TMT-127. Samples were then 
combined after labeling prior to nano-LC-MS/MS analysis. 
3.3. Nano-LC-MS/MS of eIF Proteins 
All samples underwent complete labeling and were combined as outlined in our protocol [19,27] 
prior to nano-LC-MS/MS analysis using an LTQ-Orbitrap XL (Thermo Fisher, San Jose, CA, USA) 
mass spectrometer equipped with an ADVANCE ion max source (Michrom Bioresources Inc., Auburn, 
CA, USA), a Surveyor MS pump (Thermo Fisher, San Jose, CA, USA), and a microautosampler 
(Thermo Fisher, San Jose, CA, USA). Samples were loaded onto the column for 30 min at 2% solvent 
B (0.1% (v/v) formic acid in acetonitrile) with 98% solvent A at a flow rate of 750 nL/min. Peptides 
were eluted off the column at 750 nL/min using the following gradient: 2%–10% solvent B for 5 min, 
10%–35% solvent B for 65 min, 35%–70% solvent B for 5 min, 35%–70% solvent B for  
5 min, 70%–90% solvent B for 5 min, 90% solvent B for 5 min, then reversed to 2% solvent B for  
10 min. All ions with TMT labels were analyzed via higher energy collision dissociation (HCD), all 
others with collision-induced dissociation (CID). Settings for the LTQ-Orbitrap XL were set as 
follows: data-dependent scan of the top 5 most abundant ions, minimum signal threshold of 55,000, 
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collision energy set to 35%, resolution set to 30,000, dynamic exclusion set to 60 s, repeat count set to 
2, and repeat duration set to 30 s. All RAW data were deposited directly into SEQUEST Bioworks 
3.3.1 (Thermo Fisher, San Jose, CA, USA) and manually validated. Searches were conducted against 
an in-house developed database consisting of 584 proteins containing the sequences of all known 
mammalian eukaryotic initiation factors as well as their reversed sequences. Common contaminants 
including human keratins, porcine trypsin, bovine serum albumin, bovine beta-casein, as well as their 
reversed sequences were also included. We performed searches with tryptic specificity and allowed for 
three missed cleavages at a tolerance of 20 ppm in MS mode and 0.2 Da in MS2 mode. Possible 
structure modifications included for consideration were N-terminal and lysine TMT labeling, methionine 
oxidation, carbamidomethylation of cysteine, and serine, threonine, and tyrosine phosphorylation. 
Peptides with Xcorr scores greater than 2.5 were considered for further manual validation. All TMT 
ratios were measured individually and experiments were carried out in triplicate. 
4. Conclusions 
This study represents the first global attempt to elucidate the levels of phosphorylation for three 
integral protein complexes in the translation initiation pathway (Table 1). Prior studies have revealed 
the identification of new and novel phosphosites within proteins. In this current investigation, we have 
provided quantification of phosphosites that may aid in further research of these important sites of 
regulation. As phosphorylation is a highly dynamic modification itself involving enzymatic addition 
and removal, levels of phosphorylation may be indicative of a more subtle mechanism of regulation 
incapable of being observed by identification of novel phosphosites alone. We have concentrated on 
those sites within this investigation that exhibit high levels of phosphorylation; however, those that 
display lower levels should not be ignored as gain or absence of function at those residues may be less 
sensitive to the absolute level of their phosphorylation. Phosphorylation levels appear to be at their 
highest when the residues are within a region known to be involved in binding to other proteins, metal 
ions, or nucleic acids. Phosphomimetic studies will ultimately unravel the significance of these 
phosphosites, which may be critical to protein structure and function as well as to overall influence on 
the translation initiation process. 
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